Cas:54983-54-9 sodium,4-chloro-3,5-dimethylphenolate manufacturer & supplier

We serve Chemical Name:sodium,4-chloro-3,5-dimethylphenolate CAS:54983-54-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

sodium,4-chloro-3,5-dimethylphenolate

Chemical Name:sodium,4-chloro-3,5-dimethylphenolate
CAS.NO:54983-54-9
Synonyms:Sodium 3,5-dimethyl-4-chlorophenate;EINECS 259-424-1;Phenol,4-chloro-3,5-dimethyl-,sodium salt (1:1);Phenol,4-chloro-3,5-dimethyl-,sodium salt;Sodium 4-chloro-3,5-dimethylphenolate;Sodium 3,5-dimethyl-4-chlorophenolate
Molecular Formula:C8H8ClNaO
Molecular Weight:178.59100
HS Code:

Physical and Chemical Properties:
Melting point:115.5ºC
Boiling point:246ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:23.06000
Exact Mass:178.01600
LogP:3.10060

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Sodium 3,5-dimethyl-4-chlorophenate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sodium 3,5-dimethyl-4-chlorophenolate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Phenol,4-chloro-3,5-dimethyl-,sodium salt (1:1) Use and application,Sodium 3,5-dimethyl-4-chlorophenolate technical grade,usp/ep/jp grade.


Related News: The three products for which it received the PLI approvals are betamethasone with a production capacity of 12 MT at an investment of Rs 31.43 crore, dexamethasone of 10 MT with an investment of Rs. 26.19 crore and prednisolone of 15 MT at Rs 39. 29 crore. This takes the total investment to Rs 96.91 core. 2-chloro-4-hydroxy-5-nitrobenzoic acid manufacturers The license, granted by the Medicines and Healthcare Products Regulatory Agency (MHRA), allows Onyx to support API projects from pre-clinical studies to low volume commercial manufacture. 4-(2,4-Difluorobenzyl)piperidine suppliers ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged. Nonyl trichlorosilane vendor & factory.